Metabolic Syndrome: Pipeline Analysis and U.S. Market ForecastCHI Insight Pharma ReportsJanuary 1, 2005 152 Pages - SKU: CHI1080432 |
|
Freedonia Focus on Diabetes Monitoring Products: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand for diabetes monitoring products for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size, product and market segmentation, regulatory considerations, product development, market environment, product
|
more...
|
$600.00
|
|
Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends
3/1/2012 | published by: Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, and consumers alike—of the instrumental role diet plays in a
|
more...
|
$3,500.00
|
|
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2012 provides data on the Diabetic Retinopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Anti-Diabetic Pharmaceuticals Market in India 2012
3/30/2012 | published by: Netscribes (India) Pvt. Ltd.
Anti-diabetic pharmaceuticals market in India is one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world after China, the Indian market is characterized by
|
more...
|
$795.00
|
|
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018
2/29/2012 | published by: GlobalData
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source
|
more...
|
$3,995.00
|
|
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020
2/29/2012 | published by: GlobalData
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report
|
more...
|
$6,995.00
|
|
Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2012', provides an overview of the Type 1 Diabetes (Juvenile Diabetes) therapeutic pipeline. This
|
more...
|
$500.00
|
|
Obesity – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Obesity – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Obesity - Pipeline Review, H1 2012', provides an overview of the Obesity therapeutic pipeline. This report provides information on the therapeutic development for Obesity, complete with latest
|
more...
|
$500.00
|
|
Diabetic Foot Ulcers – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetic Foot Ulcers – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetic Foot Ulcers - Pipeline Review, H1 2012', provides an overview of the Diabetic Foot Ulcers therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
|
Diabetes – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
Diabetes – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2012', provides an overview of the Diabetes therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest
|
more...
|
$500.00
|
